Sort
46,585 grants matching “heart failure”
The neural circuitry of seizure-induced apnea and SUDEP
$403,750Ian Christopher Wenker · University Of Virginia · R01 · FY2025 · NS
Osteogenic Regulation of Vascular Calcification
$403,750Dwight A Towler · Ut Southwestern Medical Center · R01 · FY2016 · HL
Role of Foxa2 in ligand-dependent activation of nuclear receptors
$403,750Irina Bochkis · University Of Virginia · R01 · FY2023 · DK
Optical imaging in the development of molecularly targeted AAV for cardiac regeneration after myocardial infarction
$403,750Brent A French · University Of Virginia · R01 · FY2020 · HL
Mosaic loss of Y chromosome in blood and heart failure
$403,750Kenneth Walsh · University Of Virginia · R01 · FY2023 · AG
Role of therapy-related clonal hematopoiesis in anthracycline-induced cardiotoxicity
$403,750Kenneth Walsh · University Of Virginia · R01 · FY2020 · HL
INVESTIGATION OF A NEWLY DISCOVERED ORGANELLE-BASED SIGNALING PARADIGM
$403,750Roshanak Irannejad · University Of California, San Francisco · R35 · FY2022 · GM
INVESTIGATION OF A NEWLY DISCOVERED ORGANELLE-BASED SIGNALING PARADIGM
$403,750Roshanak Irannejad · University Of California, San Francisco · R35 · FY2023 · GM
IRF4-dependent T-cell effector programs in governing transplant outcomes
$403,750Wenhao Chen · Methodist Hospital Research Institute · R01 · FY2020 · AI
Optical imaging in the development of molecularly targeted AAV for cardiac regeneration after myocardial infarction
$403,750Brent A French · University Of Virginia · R01 · FY2021 · HL
Role of therapy-related clonal hematopoiesis in anthracycline-induced cardiotoxicity
$403,750Kenneth Walsh · University Of Virginia · R01 · FY2022 · HL
Mechanisms driving cardiac dysfunction in Autosomal Dominant Polycystic Kidney Disease
$403,750Francisco Altamirano · Methodist Hospital Research Institute · R01 · FY2022 · HL
Optical imaging in the development of molecularly targeted AAV for cardiac regeneration after myocardial infarction
$403,750Brent A French · University Of Virginia · R01 · FY2019 · HL
DYRK1a as a therapeutic target to treat myocardial infarction
$403,750Matthew J Wolf · University Of Virginia · R01 · FY2022 · HL
SIGNALING PATHWAYS IN HEART FAILURE
$403,750Boston University Medical Campus · R01 · FY2005 · HL
INVESTIGATION OF A NEWLY DISCOVERED ORGANELLE-BASED SIGNALING PARADIGM
$403,750Roshanak Irannejad · University Of California, San Francisco · R35 · FY2021 · GM
Optical imaging in the development of molecularly targeted AAV for cardiac regeneration after myocardial infarction
$403,750Brent A French · University Of Virginia · R01 · FY2022 · HL
IRF4-dependent T-cell effector programs in governing transplant outcomes
$403,750Wenhao Chen · Methodist Hospital Research Institute · R01 · FY2021 · AI
IRF4-dependent T-cell effector programs in governing transplant outcomes
$403,750Wenhao Chen · Methodist Hospital Research Institute · R01 · FY2018 · AI
IRF4-dependent T-cell effector programs in governing transplant outcomes
$403,750Wenhao Chen · Methodist Hospital Research Institute · R01 · FY2022 · AI
Role of therapy-related clonal hematopoiesis in anthracycline-induced cardiotoxicity
$403,750Kenneth Walsh · University Of Virginia · R01 · FY2021 · HL
The neural circuitry of seizure-induced apnea and SUDEP
$403,750Ian Christopher Wenker · University Of Virginia · R01 · FY2023 · NS
Mechanisms driving cardiac dysfunction in Autosomal Dominant Polycystic Kidney Disease
$403,750Francisco Altamirano · Methodist Hospital Research Institute · R01 · FY2025 · HL
DYRK1a as a therapeutic target to treat myocardial infarction
$403,750Matthew J Wolf · University Of Virginia · R01 · FY2024 · HL
Mechanisms driving cardiac dysfunction in Autosomal Dominant Polycystic Kidney Disease
$403,750Francisco Altamirano · Methodist Hospital Research Institute · R01 · FY2023 · HL